Vik Chopra
Stock Analyst at Wells Fargo
(1.57)
# 3,432
Out of 4,996 analysts
50
Total ratings
28.57%
Success rate
-7.75%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $79 → $82 | $70.46 | +16.38% | 5 | Sep 15, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $17 → $15 | $10.01 | +49.85% | 3 | Aug 13, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $76 → $66 | $55.10 | +19.78% | 10 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Overweight | $48 → $41 | $30.02 | +36.58% | 4 | Aug 8, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $16 → $15 | $12.37 | +21.26% | 3 | Aug 8, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $17 → $19 | $19.99 | -4.95% | 3 | Aug 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $246 → $199 | $124.88 | +59.35% | 3 | Jul 31, 2025 | |
| MASI Masimo | Maintains: Overweight | $205 → $190 | $139.75 | +35.96% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $13.18 | -1.37% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $65.64 | +14.26% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $57 | $45.99 | +23.94% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $15.39 | +23.46% | 1 | Aug 1, 2024 |
Solventum
Sep 15, 2025
Maintains: Equal-Weight
Price Target: $79 → $82
Current: $70.46
Upside: +16.38%
NeuroPace
Aug 13, 2025
Maintains: Overweight
Price Target: $17 → $15
Current: $10.01
Upside: +49.85%
Globus Medical
Aug 8, 2025
Maintains: Overweight
Price Target: $76 → $66
Current: $55.10
Upside: +19.78%
Enovis
Aug 8, 2025
Maintains: Overweight
Price Target: $48 → $41
Current: $30.02
Upside: +36.58%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $16 → $15
Current: $12.37
Upside: +21.26%
Envista Holdings
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $17 → $19
Current: $19.99
Upside: -4.95%
Align Technology
Jul 31, 2025
Maintains: Overweight
Price Target: $246 → $199
Current: $124.88
Upside: +59.35%
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $139.75
Upside: +35.96%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $13.18
Upside: -1.37%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $65.64
Upside: +14.26%
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $45.99
Upside: +23.94%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $15.39
Upside: +23.46%